News

Aehr Test Systems beat quarterly estimates and issued FY2027 revenue guidance of $130-$150 million, backed by a $100.6 million backlog and improved gross margins.

Aehr stock soars on blockbuster Q2 earnings and impressive future guidance. But Wall Street sees AEHR shares as overvalued at current levels.

Aehr Test Systems climbed by 21.91 percent on Wednesday to close at $87.79 apiece, after management projected a sharp acceleration in its full-year growth for fiscal 2027, underpinned by a record backlog and the continued strong demand for semiconductor testing solutions in AI infrastructure. In an earnings call on Tuesday, the company said that it […]

Aehr Test Systems (NASDAQ:AEHR) shares jumped 30% after the semiconductor test and burn-in equipment provider reported fiscal fourth-quarter results that exceeded Wall Street expectations and provided a stronger-than-anticipated revenue outlook for fiscal 2027. The company posted adjusted...

Aehr Test Systems targets $130M-$150M in fiscal 2027 revenues as AI processors, silicon photonics and record backlog fuel a major ramp.

Despite a dip in full-year revenue, Aehr Test Systems (AEHR) projects significant growth in fiscal 2027, driven by robust demand and expanded manufacturing capacity.

AI and data center revenue surged to 71% of annual sales.

Moby summary of Aehr Test Systems's Q4 2026 earnings call

The semiconductor equipment maker topped quarterly estimates and forecast fiscal 2027 revenue far above Wall Street expectations.

Aehr Test Systems (NASDAQ:AEHR) said it entered fiscal 2027 with record backlog and expects revenue to more than double, citing accelerating demand tied to artificial intelligence processors, silicon photonics and data center infrastructure. President and Chief Executive Officer Gayn Erickson said